About Us
Company
Contact Us
Technology
Pipeline
News
Events
Press Releases
Publications
Join Us
中文
Company
Technology
Pipeline
News
Publications
Join Us
Contact Us
Press Releases
Home
News
Press Releases
Dr. Yongliang Fang on Endpoints News：Chinese biotech unveils first-in-class tri-agonist for high lipids
2025/12/31
Read more
Doer Biologics' Globally First-in-Class Drug DR10624 Phase II Clinical Data Presented in Opening Session at AHA 2025
2025/11/11
Read more
Doer Biologics Announced Completes Enrollment of the Phase 2 Clinical Study of DR10624, reported by mainstream media
2025/03/12
Read more
Doer Biologics Announced First Patient Dosed in Phase 2 Study of DR10624, reported by mainstream media
2024/10/09
Read more
Many mainstream media reported the collaboration between Zhejiang Doer Biologics and MSD
2022/12/19
Read more
Reported by PR Newswire published
2022/12/17
Read more
Doer Biologics interview by Biopharma Reporter published
2021/12/16
Read more
PR post reshared by Bioprocess international
2021/12/14
Read more
